WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Inc Stock Ownership - Who owns Agios Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Agios Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brian GoffChief Executive Officer2024-08-0811,091$42.75
$474.14kSell
Sarah GheuensChief Medical Officer2024-07-013,705$43.85
$162.46kSell
Brian GoffChief Executive Officer2024-06-0512,115$48.84
$591.70kSell
Theodore James Washburn Jr.Principal Accounting Officer2024-06-031,362$44.39
$60.46kSell
Jacqualyn A. FouseDirector2024-04-107,791$27.55
$214.64kSell
Kaye I. FostercheekDirector2024-03-071,285$31.62
$40.63kSell
Kaye I. FostercheekDirector2024-03-064,415$31.99
$141.24kSell
Kaye I. FostercheekDirector2024-03-05300$32.21
$9.66kSell
James William BurnsChief Legal Officer2024-03-051,349$32.57
$43.94kSell
James William BurnsChief Legal Officer2024-03-051,293$32.57
$42.11kSell

1 of 5

AGIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AGIO insiders and whales buy or sell their stock.

AGIO Shareholders

What type of owners hold Agios Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Celgene European Investment Co LLC10.31%5,867,279$258.39MInsider
Farallon Capital Management LLC9.94%5,654,502$249.02MInstitution
Vanguard Group Inc9.66%5,496,737$242.08MInstitution
Blackrock Inc8.54%4,859,002$213.99MInstitution
Robert Nelsen6.98%3,969,968$174.84MInsider
Bellevue Group Ag6.82%3,879,548$170.86MInstitution
Arch Venture Fund Vii LP5.43%3,088,590$136.02MInsider
Price T Rowe Associates Inc4.88%2,777,259$122.31MInstitution
Celgene Corp4.37%2,486,157$109.49MInsider
Dimensional Fund Advisors LP3.86%2,196,085$96.72MInstitution

1 of 3

AGIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGIO74.40%25.60%Net SellingNet Selling
PTGX80.41%19.59%Net SellingNet Buying
PTCT85.02%14.98%Net SellingNet Selling
CGON64.52%15.36%Net BuyingNet Selling
GERN77.05%1.20%Net BuyingNet Buying
View Top Biotech Stocks

Agios Pharmaceuticals Stock Ownership FAQ

Who owns Agios Pharmaceuticals?

Agios Pharmaceuticals (NASDAQ: AGIO) is owned by 98.22% institutional shareholders, 33.79% Agios Pharmaceuticals insiders, and 0.00% retail investors. Celgene European Investment Co LLC is the largest individual Agios Pharmaceuticals shareholder, owning 5.87M shares representing 10.31% of the company. Celgene European Investment Co LLC's Agios Pharmaceuticals shares are currently valued at $253.94M.

If you're new to stock investing, here's how to buy Agios Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.